ivWatch (@ivWatch) header
ivWatch (@ivWatch) profile picture

ivWatch, LLC - a medical device and biosensor company focused on improving patient safety through early detection of IV infiltrations and extravasations.

Newport News, VA
Joined April 2015
Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)Photo by ivWatch (@ivWatch)
ivWatch is redefining IV therapy safety. The world’s only continuous IV monitoring system is clinically proven to detect infiltration and extravasation events before visible signs appear, ivWatch helps prevent severe IV harm before it happens. Backed by decades of research and clinical validation, ivWatch continuously monitors IV site integrity in high-risk care settings. IV therapy is one of the most common procedures in healthcare, yet studies show up to 50% of IVs fail before treatment is complete, resulting in pain, tissue injury, prolonged hospital stays, and higher costs. Using a non-invasive sensor technology and a predictive algorithm, ivWatch empowers clinical teams to intervene early, improve patient outcomes, reduce liability, and drive cost savings—setting a new standard of care for IV therapy. Our mission is bold: STOP IV HARM. Watch the video and schedule a demo to see ivWatch in action: ivwatch.com/request-a-demo/ #IVSafety #PatientSafety #HealthcareInnovation #MedTech #NursingTechnology #InfiltrationDetection #ContinuousMonitoring #ClinicalExcellence #HospitalSafety #VascularAccess #InfusionTherapy #AvoidableHarm
1
2
56
In the operating room, factors such as prolonged procedures, vesicant medications, and limited IV visibility can increase the risk of infiltration. For patients under anesthesia, complications may develop without the ability to communicate discomfort. ivWatch helps support clinicians with continuous IV site monitoring, adding another layer of protection when direct observation is challenging and patients are not able to communicate discomfort. #IVSafety #OperatingRoom #PatientSafety #InfusionTherapy #Anesthesia #ivWatch
1
Great software doesn't just power a device, it helps power better patient care. As Principal Software Engineer & Architect, Nitin Mohan leads the software architecture behind ivWatch's technology, helping transform complex engineering challenges into reliable solutions for clinicians and patients. With more than 15 years of experience in embedded systems, medical device software, firmware development, and system architecture, he brings deep technical expertise to every stage of product innovation. From software design and hardware integration to technical leadership and mentoring, Nitin helps advance the technology that supports our mission of improving IV safety through continuous innovation. #EngineeringExcellence #SoftwareEngineering #MedicalDevices #HealthcareInnovation #IVSafety #IVWatch
17
Engineering innovation into patient safety takes expertise, curiosity, and a commitment to continuous improvement. As Senior Product Development Engineer at ivWatch, Marissa Marine helps advance the technology behind our mission to improve IV safety. With a Master's degree in Biomedical Engineering and expertise spanning medical device development, product design, and regulatory processes, Marissa brings a thoughtful, multidisciplinary approach to innovation. From concept through development, her work helps transform complex engineering challenges into solutions designed to support clinicians and improve patient care. #EngineeringExcellence #HealthcareInnovation #MedicalDevices #IVSafety #WomenInEngineering #IVWatch
39
In the operating room, sterile drapes are essential to patient safety. But when an IV site is tucked beneath the drape, direct visual assessment can be limited during critical moments of care. Clinicians remain focused on the patient, yet the IV site is not always visible for routine assessment. That creates a clinical gap in care and the opportunity to strengthen IV surveillance between visual checks with ivWatch. ivWatch provides continuous IV site monitoring between nursing assessments, offering an additional layer of visibility when the insertion site is difficult to observe. #ivWatch #IVSafety #OperatingRoom #Anesthesia #PatientSafety #PerioperativeCare
22
Behind every medical device innovation is the technology that keeps it moving forward. As IT Director, Chris Warren helps build and maintain the systems that support ivWatch’s operations, quality processes, and long-term growth. His expertise in enterprise applications, process improvement, and regulated environments ensures teams across the organization have the tools and infrastructure needed to advance our mission of improving IV safety. From leading the implementation and optimization of Microsoft Dynamics 365 Business Central to driving broader technology modernization initiatives, Chris helps create a connected digital ecosystem that supports efficiency, scalability, and data-driven decision-making across the business. By optimizing business systems and strengthening the technology foundation behind our operations, Chris plays a key role in helping ivWatch scale innovation and deliver value to healthcare providers and patients worldwide. #Leadership #HealthcareInnovation #MedicalDevices #InformationTechnology #DigitalTransformation #BusinessCentral #MicrosoftDynamics365 #ivWatch
18
Can IV site monitoring truly make a difference in neonatal care? Researchers evaluated more than 32,000 neonatal IV catheters and found that continuous optical monitoring was associated with fewer severe infiltration and extravasation events. The study highlights an important conversation around early detection, proactive intervention, and reducing harm before complications escalate. Scroll to see the insights or see the full study in comments section. #PatientSafety #HealthcareTechnology #NICU #Ivinfiltration #IVextravasation Read more: ivwatch.com/2025/08/14/how-c…
8
Patient safety doesn't happen by chance. It happens when committed healthcare professionals come together to challenge the status quo. That's why the ivWatch team is continuously engaging with hospitals, supporting clinical teams, and advocating for a more proactive approach to IV therapy safety. Every visit, every conversation, and every partnership brings us one step closer to eliminating avoidable IV harm. #ivWatch #PatientSafety #IVTherapy #ThoughtLeadership #HealthcareExcellence #MedTech
4
Patient care doesn't pause during shift changes. With ivWatch, clinicians can quickly review IV history, documented events, and assessment trends, providing greater visibility into what happened between bedside visits. Learn more about how continuous IV therapy monitoring can assist your clinical teams: ivwatch.com/ #IVWatch #PatientSafety #IVTherapy #IVSafety
8
Across the country, our team is meeting with nurses, clinical leaders, and healthcare teams to discuss one important goal: preventing avoidable IV harm before it happens. These conversations drive innovation, strengthen partnerships, and help us continue advancing safer IV therapy practices. We're proud to be part of the solution. #PatientSafety #IVTherapy #NursingLeadership #ClinicalExcellence #ivWatch
8
Great companies are built by people who combine expertise with purpose. Since joining ivWatch in 2023, Helen Stephens has helped drive our international growth, advancing IV safety across healthcare systems and bringing our mission to new markets around the world. With three decades of experience spanning bedside nursing, clinical leadership, business development, and medical device innovation, Helen understands both the clinical challenges providers face and the opportunities to improve patient care. As ivWatch continues to expand globally, leaders like Helen are helping turn our vision of safer IV therapy into reality. #Leadership #HealthcareInnovation #IVSafety #MedicalDevices #IVWatch
13
ivWatch proudly designs, engineers, and manufactures its technology in the United States. By controlling every stage of development and production, we ensure the highest levels of quality, reliability, and innovation in everything we deliver. Behind every device is a dedicated team that believes healthcare can be safer. Their expertise, precision, and passion fuel a mission that has been driving us since day one. American-made innovation. Global impact. Unwavering commitment to patient safety.
7
The future of IV therapy in healthcare is built on innovation, collaboration, and a relentless commitment to better patient outcomes. This week, Jay Paris and Marissa Marine are representing ivWatch at the CHKD Innovations and Evidence-Based Practice Conference, engaging with clinicians, researchers, and healthcare leaders who are advancing the standards of care for children. Every conversation, every insight, and every innovation brings us one step closer to safer care and better outcomes for patients everywhere. We're honored to be part of the discussion. Thank you to Chkd Health Center and Macon & Joan Brock Virginia Health Sciences at Old Dominion University for bringing together leaders committed to excellence in pediatric healthcare.
14
Listening to clinicians has always guided our innovation. Our latest FDA 510(k) submission for SmartTouch+ reflects a focused effort to expand the capabilities of continuous IV monitoring to peripheral IV therapies that infuse white opaque fluids such as TPN and propofol. Learn how ivWatch is working to help clinicians gain greater visibility into potential IV complications and advance patient safety across more care settings. Read the full story: innovate757.org/2026/09/10/i…
17
Periodic monitoring of IV sites is not enough. In today’s care environments, clinicians are managing high patient volumes and constant demands, making it challenging to identify IV failures at their earliest stages. The gaps between assessments can leave opportunities for complications to progress before they become visible. This isn’t about effort. It’s about having the right support to see what intermittent checks can miss. It’s time to equip clinical teams with better tools for continuous visibility, earlier detection, and safer IV care. #IVSafety #PatientSafety #InfusionTherapy #NursingLeadership #HarmPrevention #HealthcareInnovation
10
Four stories. Four lives forever changed. Not by disease. Not by diagnosis. By an IV complication that wasn't caught soon enough. A newborn. A child. An adult. A parent. IV harm doesn't discriminate. At ivWatch, our mission is simple and urgent: Make preventable IV injuries a thing of the past. Because behind every statistic is a person whose life was changed in an instant. Jack: ivwatch.com/2020/06/04/patie… Everly:ivwatch.com/2020/06/04/patie… Barby: ivwatch.com/2020/06/04/patie… Melissa:ivwatch.com/2024/10/03/a-pre… #ivWatch #PatientSafety #HealthcareTechnology #EveryPatientMatters
1
2
24
"It's just an IV.” Until it costs someone two fingers. Until it requires 25+ surgeries. Until a mother loses years of her life fighting an injury that should never have happened. Melissa Williams went in for routine surgery and left with an IV injury that would permanently change her future. One IV. One missed warning sign. A lifetime of consequences. At ivWatch, we believe preventable IV harm is unacceptable. Because behind every injury is a person, a family, and a life forever changed. It's never "just an IV.” Read more: ivwatch.com/2024/10/03/a-pre… #PatientSafety #ivWatch #IVTherapy #Extravasation #HealthcareInnovation #PreventableHarm #EveryPatientMatters
25
What if clinicians could identify IV infiltrations and extravasations associated with white-opaque infusions before they become visible? ivWatch has submitted a 510(k) to the FDA for our new SmartTouch+™ Sensor, designed to expand IV monitoring capabilities to include infiltration and extravasation events associated with both clear and white-opaque fluids, including TPN, propofol, and other lipid-based solutions. It’s another step toward our mission to reduce preventable IV harm and help clinicians intervene earlier, when patients are most vulnerable. Read more: ivwatch.com/2026/08/14/ivwat… SmartTouch+™ is patent pending and under FDA review. Not yet FDA cleared or available for commercial sale in the United States. #IVSafety #InfusionSafety #PatientSafety #VesicantAwareness #IVinfiltration #IVextravasation
1
23
Protecting patients across the continuum of care requires unwavering vigilance. During our visit with King’s College Hospital London, Dubai, we had the opportunity to learn more about their commitment to patient safety as the first hospital in the UAE to implement ivWatch across multiple clinical areas, including the NICU, PICU/Paediatrics, Day Unit/Oncology, and Emergency Department. From the smallest and most vulnerable neonatal patients to individuals receiving chemotherapy, early detection and timely intervention can play an important role in helping clinicians reduce the risk of severe tissue injury during IV therapy. We are proud to support teams dedicated to delivering safe, compassionate care at every stage of the patient journey.
34
In the United States alone, over 400 million short peripheral intravenous catheters are inserted annually. Approximately 56 million of these individuals suffer from infiltration and extravasation injuries.¹ Early detection technology identifies changes in the tissue near the IV insertion site, which is beyond the capability of the human eye. Advocate for your patients and be the reason millions are safe from severe IV injuries. Fight for clinically viable, proven technology. 1. 𝘛𝘩𝘦 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘌𝘤𝘰𝘯𝘰𝘮𝘪𝘤 𝘉𝘶𝘳𝘥𝘦𝘯𝘴 𝘰𝘧 𝘐𝘯𝘧𝘪𝘭𝘵𝘳𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘌𝘹𝘵𝘳𝘢𝘷𝘢𝘴𝘢𝘵𝘪𝘰𝘯 𝘸𝘪𝘵𝘩 𝘗𝘦𝘳𝘪𝘱𝘩𝘦𝘳𝘢𝘭 𝘐𝘯𝘵𝘳𝘢𝘷𝘦𝘯𝘰𝘶𝘴 𝘊𝘢𝘵𝘩𝘦𝘵𝘦𝘳𝘴: 𝘈 𝘊𝘰𝘯𝘵𝘦𝘮𝘱𝘰𝘳𝘢𝘳𝘺 𝘕𝘢𝘳𝘳𝘢𝘵𝘪𝘷𝘦 𝘙𝘦𝘷𝘪𝘦𝘸 (𝘨𝘢𝘷𝘪𝘯𝘱𝘶𝘣𝘭𝘪𝘴𝘩𝘦𝘳𝘴.𝘤𝘰𝘮) #PatientSafety #IVSafety #HealthcareInnovation #InfusionSafety
26
Continuous infusion site monitoring has earned a place in one of the UK's leading IV therapy standards. The newly released 2026 NIVAS Standards for Infusion Therapy and Vascular Access recognize infusion site surveillance technology as a tool to support earlier detection of infiltration and extravasation events and help improve patient safety. Read why this is an important milestone for the future of IV therapy: ivwatch.com/2026/09/02/nivas… #PatientSafety #InfusionTherapy #VascularAccess #ClinicalInnovation #ivWatch
31